|
MKI67 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62703184258817E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.18739999999118E-06 |
| Normal-vs-Stage2 |
3.798100E-02 |
| Normal-vs-Stage3 |
7.56470000000675E-05 |
| Normal-vs-Stage4 |
6.141900E-03 |
| Stage1-vs-Stage2 |
5.525000E-01 |
| Stage1-vs-Stage3 |
2.275000E-03 |
| Stage1-vs-Stage4 |
4.524200E-03 |
| Stage2-vs-Stage3 |
1.932310E-02 |
| Stage2-vs-Stage4 |
9.775900E-02 |
| Stage3-vs-Stage4 |
6.600200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.58344514856435E-13 |
| Normal-vs-AfricanAmerican |
3.87160000000497E-05 |
| Normal-vs-Asian |
6.187800E-02 |
| Caucasian-vs-AfricanAmerican |
4.239200E-01 |
| Caucasian-vs-Asian |
3.350600E-01 |
| AfricanAmerican-vs-Asian |
1.469390E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.45339337523865E-12 |
| Normal-vs-Female |
2.15849999996021E-06 |
| Male-vs-Female |
2.002100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.76420000000044E-05 |
| Normal-vs-Extreme_Weight |
3.82640000018419E-07 |
| Normal-vs-Obese |
1.50472000000068E-05 |
| Normal-vs-Extreme_Obese |
7.781700E-03 |
| Normal_Weight-vs-Extreme_Weight |
1.809370E-01 |
| Normal_Weight-vs-Obese |
2.164000E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.161200E-03 |
| Extreme_Weight-vs-Obese |
1.680210E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.805000E-03 |
| Obese-vs-Extreme_Obese |
2.637900E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.855970E-03 |
| Normal-vs-Age(41-60Yrs) |
1.90130022836854E-10 |
| Normal-vs-Age(61-80Yrs) |
1.60950000005489E-06 |
| Normal-vs-Age(81-100Yrs) |
1.951700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.917800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.001500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.140250E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.491150E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.796300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.110800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.54290000167856E-09 |
| Normal-VS-Type2 PRCC |
2.63849999626586E-08 |
| Normal-VS-KIRP CIMP |
2.723900E-03 |
| Normal-VS-Unclassified PRCC |
6.00389999999562E-05 |
| Type1 PRCC-VS-Type2 PRCC |
7.800100E-03 |
| Type1 PRCC-VS-KIRP CIMP |
5.422800E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
1.851680E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.077610E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
5.709200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.438220E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.18869999999827E-05 |
| Normal-vs-N1 |
1.55974999999087E-05 |
| Normal-vs-N2 |
9.885900E-02 |
| N0-vs-N1 |
7.405500E-04 |
| N0-vs-N2 |
1.084360E-01 |
| N1-vs-N2 |
4.830000E-01 |
|
|
